The impact of quantitative platform on candidacy for bronchoscopic lung volume reduction: a multi-center retrospective cohort study.

ABSTRACT:

Background

Bronchoscopic lung volume reduction (BLVR) can be an effective treatment for highly selected patients with severe emphysema but only half of carefully selected patients derive clinical benefit. Two commercially available platforms exist to help determine candidacy for BLVR via quantitative analysis of computed tomography (CT) scans.

Objectives

To determine if the two commercially available quantitative platforms identified the same patient population that may benefit from BLVR.

Design

A multicenter, retrospective cohort study.

Methods

Consecutive patients referred for BLVR between January 1, 2022 and March 31, 2023 at three medical centers in the United States with the same CT scan submitted for quantitative analysis to two commercially available pla

SUBMITTER: Wayne M 

PROVIDER: S-EPMC11783484 | biostudies-literature | 2025 Jan-Dec

REPOSITORIES: biostudies-literature